Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Pharmacopsychiatry. 1996 May;29(3):103-7.

    Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Data from a randomized prospective trial.

    Source

    Department of Psychiatry, Freie Universität Berlin, Germany.

    Abstract

    Recent findings have indicated that lithium treatment markedly reduces suicide risk in major affective disorders. To compare the effect of lithium with carbamazepine and amitriptyline, suicidal behavior was analyzed during the randomized prospective long-term MAP study (N = 378; duration 2.5 years). Of the nine suicides and five attempted suicides, none took place during lithium treatment. The findings support the view that lithium has a specific antisuicidal effect over and above its prophylactic benefit.

    PMID:
    8738314
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Georg Thieme Verlag Stuttgart, New York

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk